| Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study Ø Fluge, O Bruland, K Risa, A Storstein, EK Kristoffersen, D Sapkota, ... PloS one 6 (10), e26358, 2011 | 300 | 2011 |
| Disruption of a long distance regulatory region upstream of SOX9 in isolated disorders of sex development S Benko, CT Gordon, D Mallet, R Sreenivasan, C Thauvin-Robinet, ... Journal of medical genetics 48 (12), 825-830, 2011 | 209 | 2011 |
| Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome Ø Fluge, O Mella, O Bruland, K Risa, SE Dyrstad, K Alme, IG Rekeland, ... JCI insight 1 (21), 2016 | 187 | 2016 |
| Gene expression in poorly differentiated papillary thyroid carcinomas Φ Fluge, O Bruland, LA Akslen, JR Lillehaug, JE Varhaug Thyroid 16 (2), 161-175, 2006 | 182 | 2006 |
| B-lymphocyte depletion in myalgic encephalopathy/chronic fatigue syndrome. An open-label phase II study with rituximab maintenance treatment Ø Fluge, K Risa, S Lunde, K Alme, IG Rekeland, D Sapkota, ... PloS one 10 (7), e0129898, 2015 | 164 | 2015 |
| Upregulated PDK4 expression is a sensitive marker of increased fatty acid oxidation IKN Pettersen, D Tusubira, H Ashrafi, SE Dyrstad, L Hansen, XZ Liu, ... Mitochondrion 49, 97-110, 2019 | 98 | 2019 |
| B-lymphocyte depletion in patients with myalgic encephalomyelitis/chronic fatigue syndrome: a randomized, double-blind, placebo-controlled trial Ø Fluge, IG Rekeland, K Lien, H Thürmer, PC Borchgrevink, C Schäfer, ... Annals of internal medicine 170 (9), 585-593, 2019 | 93 | 2019 |
| Serum/glucocorticoid-regulated kinase 1 (SGK1) is a prominent target gene of the transcriptional response to cytokines in multiple myeloma and supports the growth of myeloma cells UM Fagerli, K Ullrich, T Stühmer, T Holien, K Köchert, RU Holt, O Bruland, ... Oncogene 30 (28), 3198-3206, 2011 | 84 | 2011 |
| STUB1 mutations in autosomal recessive ataxias – evidence for mutation-specific clinical heterogeneity K Heimdal, M Sanchez-Guixé, I Aukrust, J Bollerslev, O Bruland, ... Orphanet journal of rare diseases 9, 1-12, 2014 | 81 | 2014 |
| MicroRNA-15b is induced with E2F-controlled genes in HPV-related cancer MP Myklebust, O Bruland, Ø Fluge, A Skarstein, L Balteskard, O Dahl British journal of cancer 105 (11), 1719-1725, 2011 | 74 | 2011 |
| NATH, a novel gene overexpressed in papillary thyroid carcinomas Ø Fluge, O Bruland, LA Akslen, JE Varhaug, JR Lillehaug Oncogene 21 (33), 5056-5068, 2002 | 70 | 2002 |
| PKU mutation (D143G) associated with an apparent high residual enzyme activity: expression of a kinetic variant form of phenylalanine hydroxylase in three different systems PM Knappskog, HG Eiken, A Martínez, O Bruland, J Apold, T Flatmark Human Mutation 8 (3), 236-246, 1996 | 64 | 1996 |
| S100A14 regulates the invasive potential of oral squamous cell carcinoma derived cell-lines in vitro by modulating expression of matrix metalloproteinases, MMP1 and MMP9 D Sapkota, O Bruland, DE Costea, H Haugen, EN Vasstrand, SO Ibrahim European Journal of Cancer 47 (4), 600-610, 2011 | 63 | 2011 |
| Genetic landscape of sporadic vestibular schwannoma AL Håvik, O Bruland, E Myrseth, H Miletic, M Aarhus, PM Knappskog, ... Journal of neurosurgery 128 (3), 911-922, 2017 | 61 | 2017 |
| Expression of DSG1 and DSC1 are prognostic markers in anal carcinoma patients MP Myklebust, Ø Fluge, H Immervoll, A Skarstein, L Balteskard, O Bruland, ... British journal of cancer 106 (4), 756-762, 2012 | 58 | 2012 |
| Platelet-derived growth factor (PDGF)-C, a PDGF family member with a vascular endothelial growth factor-like structure LJ Reigstad, HM Sande, Ø Fluge, O Bruland, A Muga, JE Varhaug, ... Journal of Biological Chemistry 278 (19), 17114-17120, 2003 | 56 | 2003 |
| Global gene expression profiling and tissue microarray reveal novel candidate genes and down-regulation of the tumor suppressor gene CAV1 in sporadic vestibular schwannomas M Aarhus, O Bruland, HA Sætran, SJ Mork, M Lund-Johansen, ... Neurosurgery 67 (4), 998-1019, 2010 | 53 | 2010 |
| Expression profile of the S100 gene family members in oral squamous cell carcinomas D Sapkota, O Bruland, OE Bøe, H Bakeer, OAA Elgindi, EN Vasstrand, ... Journal of oral pathology & medicine 37 (10), 607-615, 2008 | 50 | 2008 |
| Gene expression profile of oral squamous cell carcinomas from Sri Lankan betel quid users ML Suhr, B Dysvik, O Bruland, S Warnakulasuriya, AN Amaratunga, ... Oncology reports 18 (5), 1061-1075, 2007 | 49 | 2007 |
| S100A14 inhibits proliferation of oral carcinoma derived cells through G1-arrest D Sapkota, DE Costea, M Blø, O Bruland, JB Lorens, EN Vasstrand, ... Oral oncology 48 (3), 219-225, 2012 | 47 | 2012 |
Dipak SapkotaProfessor, Department of Oral Biology, Universtiy of OsloVerified email at odont.uio.no
